Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4

다국어 초록 (Multilingual Abstract)

Background/Aims: Binge drinking leads to many disorders, including alcoholic hepatosteatosis, which is characterized by intrahepatic neutrophil infiltration and increases the risk of hepatocellular carcinoma (HCC). Molecular mechanisms may involve the migration of bacterial metabolites from the gut to the liver and the activation of neutrophil extracellular traps (NETs).
Methods: Serum samples from both binge drinking and alcohol-avoiding patients were analyzed. Mouse models of chronic plus binge alcohol-induced hepatosteatosis and HCC models were used.
Results: A marker of NETs formation, lipopolysaccharide (LPS), was significantly higher in alcoholic hepatosteatosis and HCC patients and mice than in controls. Intrahepatic inflammation markers and HCC-related cytokines were decreased in mice with reduced NET formation due to neutrophil elastase (NE) deletion, and liver-related symptoms of alcohol were also alleviated in NE knockout mice. Removal of intestinal bacteria with antibiotics led to decreases in markers of NETs formation and inflammatory cytokines upon chronic alcohol consumption, and development of alcoholic hepatosteatosis and HCC was also attenuated. These functions were restored upon supplementation with the bacterial product LPS. When mice lacking toll-like receptor 4 (TLR4) received chronic alcohol feeding, intrahepatic markers of NETs formation decreased, and hepatosteatosis and HCC were alleviated.
Conclusions: Formation of NETs following LPS stimulation of TLR4 upon chronic alcohol use leads to increased alcoholic steatosis and subsequent HCC.

참고문헌 (Reference)

1 World Health Organization (WHO), "lobal status report on alcohol and health 2018"

2 Singh V, "Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota" 11 : 1077-1091, 2020

3 Guo J, "Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis" 3 : 21-, 2010

4 Machida K, "Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog" 106 : 1548-1553, 2009

5 Yan J, "The role of the liver in sepsis" 33 : 498-510, 2014

6 McGlynn KA, "The global epidemiology of hepatocellular carcinoma : present and future" 15 : 223-243, 2011

7 Zhou Z, "Targeting the gut barrier for the treatment of alcoholic liver disease" 1 : 197-207, 2017

8 Munir S, "TLR4-dependent shaping of the wound site by MSCs accelerates wound healing" 21 : e48777-, 2020

9 Arroyo R, "SP-D attenuates LPS-induced formation of human neutrophil extracellular traps(NETs), protecting pulmonary surfactant inactivation by NETs" 2 : 470-, 2019

10 Ohtani N, "Role of the gut-liver axis in liver inflammation, fibrosis, and cancer : a special focus on the gut microbiota relationship" 3 : 456-470, 2019

11 Hassan MM, "Risk factors for hepatocellular carcinoma : synergism of alcohol with viral hepatitis and diabetes mellitus" 36 : 1206-1213, 2002

12 Cichon I, "Reduced neutrophil extracellular trap(NET)formation during systemic inflammation in mice with menkes disease and wilson disease : copper requirement for NET release" 10 : 3021-, 2020

13 Dapito DH, "Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4" 21 : 504-516, 2012

14 Matsumoto K, "Platelet CXCL4 mediates neutrophil extracellular traps formation in ANCA-associated vasculitis" 11 : 222-, 2021

15 Celli R, "Pathology of alcoholic liver disease" 2 : 103-109, 2014

16 Santocki M, "On neutrophil extracellular trap(NET)removal : what we know thus far and why so little" 9 : 2079-, 2020

17 Margetts J, "Neutrophils : driving progression and poor prognosis in hepatocellular carcinoma?" 118 : 248-257, 2018

18 Zhou Z, "Neutrophil-hepatic stellate cell interactions promote fibrosis in experimental steatohepatitis" 5 : 399-413, 2018

19 van der Windt DJ, "Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis" 68 : 1347-1360, 2018

20 Du J, "Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients" 46 : 101697-, 2022

21 Papayannopoulos V, "Neutrophil extracellular traps in immunity and disease" 18 : 134-147, 2018

22 Wilson CL, "NFκB1is a suppressor of neutrophil-driven hepatocellular carcinoma" 6 : 6818-, 2015

23 Kolaczkowska E, "Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature" 6 : 6673-, 2015

24 Sung H, "Microbiota-based treatments in alcoholic liver disease" 22 : 6673-6682, 2016

25 Wieser V, "Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease" 64 : 872-880, 2016

26 McDonald B, "Kupffer cells and activation of endothelial TLR4 coordinate neutrophil adhesion within liver sinusoids during endotoxemia" 305 : G797-G806, 2013

27 Yang LY, "Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response" 13 : 3-, 2020

28 Carpino G, "Increased liver localization of lipopolysaccharides in human and experimental NAFLD" 72 : 470-485, 2020

29 Pekow JR, "Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis" 109 : 2490-2496, 2007

30 Leitão HS, "Hepatic fibrosis, inflammation, and steatosis : influence on the MR viscoelastic and diffusion parameters in patients with chronic liver disease" 283 : 98-107, 2017

31 Toffanin S, "HCC is promoted by bacterial translocation and TLR-4 signaling : a new paradigm for chemoprevention and management" 56 : 1998-2000, 2012

32 Szabo G, "Gut-liver axis in alcoholic liver disease" 148 : 30-36, 2015

33 Li YM, "Guidelines of prevention and treatment for alcoholic liver disease(2018, China)" 20 : 174-180, 2019

34 Llorente C, "Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus" 8 : 837-, 2017

35 Bode C, "Effect of alcohol consumption on the gut" 17 : 575-592, 2003

36 Huang H, "Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury" 62 : 600-614, 2015

37 Bertola A, "Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice : a critical role for E-selectin" 58 : 1814-1823, 2013

38 Gonda TA, "Chronic inflammation, the tumor microenvironment and carcinogenesis" 8 : 2005-2013, 2009

39 Brandon-Warner E, "Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis" 36 : 641-653, 2012

40 Wartha F, "Capsule and D-alanylated lipoteichoic acids protect streptococcus pneumoniae against neutrophil extracellular traps" 9 : 1162-1171, 2007

41 Fan JH, "Attributable causes of liver cancer mortality and incidence in china" 14 : 7251-7256, 2013

42 Li Y, "Association between alcohol consumption and cancers in the Chinese population--a systematic review and meta-analysis" 6 : e18776-, 2011

43 Seitz HK, "Alcoholic liver disease" 4 : 16-, 2018

44 Lowe PP, "Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice" 12 : e0174544-, 2017

45 Bala S, "Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease" 102 : 487-498, 2017

46 Bajaj JS, "Alcohol, liver disease and the gut microbiota" 16 : 235-246, 2019

47 Meroni M, "Alcohol or gut microbiota : who is the guilty?" 20 : 4568-, 2019

48 Bukong TN, "Abnormal neutrophil traps and impaired efferocytosis contribute to liver injury and sepsis severity after binge alcohol use" 69 : 1145-1154, 2018

49 Liu Y, "A role for intestinal alkaline phosphatase in preventing liver fibrosis" 11 : 14-26, 2021